VRX-03011, a novel 5-HT4 agonist, enhances memory and hippocampal acetylcholine efflux
- 1 September 2007
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 53 (4) , 563-573
- https://doi.org/10.1016/j.neuropharm.2007.06.016
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- 5‐HT4receptor agonists increase sAPPα levels in the cortex and hippocampus of male C57BL/6j miceBritish Journal of Pharmacology, 2007
- Treatment effects of rivastigmine on cognition, performance of daily living activities and behaviour in Alzheimer's disease in an outpatient geriatric settingInternational Journal Of Clinical Practice, 2006
- Cognitive impairment in preclinical Alzheimer's disease: A meta-analysis.Neuropsychology, 2005
- Tegaserod (Zelnorm) for irritable bowel syndrome: reports of serious diarrhea and intestinal ischemiaCMAJ : Canadian Medical Association Journal, 2004
- A secreted form of the β-amyloid precursor protein (sAPP695) improves spatial recognition memory in OF1 miceNeurobiology of Learning and Memory, 2004
- Age at onset is associated with disease severity in Lewy body variant and Alzheimerʼs diseaseNeuroReport, 2002
- Memory Impairment Differs in Frontotemporal Dementia and Alzhemier’s Disease.Neurocase, 2001
- Brain microdialysis and its application for the study of animal behaviourBehavioural Brain Research, 1995
- Glucose effects on mecamylamine-induced memory deficits and decreases in locomotor activity in miceBehavioral and Neural Biology, 1991
- Spontaneous alternation behavior.Psychological Bulletin, 1958